Showing 118 of 118on this page. Filters & sort apply to loaded results; URL updates for sharing.118 of 118 on this page
BioCryst Adds $350 Million in New Financing with Royalty Pharma and ...
BioCryst Rare Disease Therapy Gets Orphan Drug Status From FDA | North ...
BioCryst Pharmaceuticals Logo PNG Vector (CDR) Free Download
BioCryst announces RAPIVAB(TM) trial results for the treatment of ...
FDA Approves BioCryst Drug, First Oral Therapy for Rare Disease HAE ...
BioCryst® | A Pioneer in Rare Disease Therapeutics | BioCryst ...
BioCryst Announces FDA Approval of ORLADEYO™ (berotralstat), First Oral ...
Rare Disease Day 2025 | BioCryst Pharmaceuticals, Inc.
BioCryst Breaks Even, Stocks Soar: A Rare Win for a Rare Disease ...
#rarediseases | BioCryst Pharmaceuticals, Inc.
Rare Disease Day 2026 | BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. on LinkedIn: Learn more about our unique ...
BioCryst - A Pioneer in Rare Disease Therapeutics
BioCryst Strengthens Rare Disease Leadership With Astria Acquisition ...
BioCryst begins phase 1 trial with BCX9250 for treatment of ...
BioCryst debuts print magazine for hereditary angioedema patients ...
BioCryst goes ‘all in’ on rare swelling disease with Astria deal ...
BioCryst | Canada | Home
BioCryst launches awareness campaign around management of rare vascular ...
BioCryst deepens rare diseases focus with $700 million deal for Astria ...
BioCryst Pharmaceuticals, Inc. on LinkedIn: Rare Disease Day 2024
Homepage | BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals: A High-Conviction Biotech Play with a ...
Biocryst pharmaceuticals hi-res stock photography and images - Alamy
FDA accepts our drug for kids with HAE | BioCryst Pharmaceuticals, Inc ...
BioCryst | Royalty Pharma
BioCryst closes $700M deal for rare disease drug Astria - Triangle ...
BioCryst Pharmaceuticals, Inc. on LinkedIn: BioCryst | Oral Drugs for ...
BioCryst Pharmaceuticals (BCRX) FDA Approvals, PDUFA Dates & Drug ...
BioCryst stock surges on HHS award to develop peramivir for people with ...
#eci2024 | BioCryst Pharmaceuticals, Inc.
Needling BioCryst
BioCryst Awarded FDA Approval for Medicine Preventing Attacks in HAE ...
BioCryst Pharmaceuticals, Inc. Stock — BCRX Overview — Roic AI
#rarediseaseday | BioCryst Pharmaceuticals, Inc.
BioCryst Begins Proof of Concept Trial in PNH Patients With Oral Factor ...
BioCryst to explore oral liquid formulation of BCX7353 for use in Acute ...
BioCryst Successfully Completes its Phase 1 Clinical Trial of BCX4161 ...
BioCryst (BCRX) Stock: Soars with FDA Approval for Pediatric ORLADEYO ...
Upcoming Catalysts Make BioCryst Pharmaceuticals a Stock to Watch Out for!
BioCryst Pharmaceuticals, Inc. on LinkedIn: Rare Disease Day 2025
BioCryst Acquires Astria Therapeutics for $700 Million to Expand ...
BioCryst Pharmaceuticals - Crunchbase Company Profile & Funding
BioCryst Pharmaceuticals (BCRX): Valuation Check After Positive APeX-P ...
BioCryst Pharmaceuticals, Inc. on LinkedIn: #raredisease
#rarediseaseday #lightupforrare | BioCryst Pharmaceuticals, Inc.
6 things to know before the readout of BioCryst Pharma's key clinical trial
#hae | BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc.: Culture | LinkedIn
BioCryst inks $700M Astria deal to rival Takeda in rare disease
BioCryst Pharmaceuticals, Inc. on LinkedIn: #raredisease #rarediseases ...
BioCryst Completes Acquisition of Astria Therapeutics, Strengthening ...
生物技术公司：Biocryst医药 BioCryst Pharmaceuticals(BCRX) | 美股之家
BioCryst logo, Vector Logo of BioCryst brand free download (eps, ai ...
#biotech #rarediseases | BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals' stock jumps after FDA decision - al.com
BioCryst Pharmaceuticals: A Strategic Blueprint for $1 Billion in ...
Two Key Products Drive BioCryst (BCRX) to New Highs - TipRanks.com
BioCryst | Research Triangle Park
BioCryst Logo PNG Transparent & SVG Vector - Freebie Supply
Biocryst Logo Biotechnology News & Articles | NC Biotech
#interns | BioCryst Pharmaceuticals, Inc.
Biocryst - France Biotech
BioCryst Q4 2022 Presentation: Key Therapeutic Innovations Highlighted ...
BioCryst Pharmaceuticals, Inc. on LinkedIn: #rarediseaseday #lightupforrare
This Photo Illustration Biocryst Pharmaceuticals Logo Editorial Stock ...
BioCryst Pharmaceuticals Launches Groundbreaking HAE Treatment ...
BioCryst Pharmaceuticals 2026 Company Profile: Stock Performance ...
#pnh | BioCryst Pharmaceuticals, Inc.
BioCryst® | A Pioneer in Rare Disease Therapeutics
Rare Disease Pharmaceuticals | BioCryst®
The EC Approves Ionis and Otsuka’s Dawnzera (Donidalorsen) as a ...
FDA approves BioCryst’s oral pellet version of rare disease drug for ...
Our focus is on addressing the highly unmet needs of rare disease ...
Home | Biocryst®
At BioCryst, our team is bound by a common goal: to deliver medicines ...
In a recent interview, Luke Robinson, General Manager, UK, Ireland, and ...
Patient Advocacy | BioCryst®
Therapeutic Areas | Swixx BioPharma | Modern Medicines for All
Today we announced the sale of our European business to Neopharmed ...
We are excited to connect with the angioedema community at the 2024 ...
Today we announced updates to our drug discovery process and additional ...
We are committed to discovering and developing small-molecule and ...
